FindTrial
Sign In

Risk factors for drug-resistant pathogens in community-onset pneumonia: a systematic review and meta-analysis

Risk factors for drug-resistant pathogens in community-onset pneumonia: a systematic review and meta-analysis - Risk factors for drug-resistant pathogens in community-onset pneumonia: a systematic review and meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000049116
Enrollment
Unknown
Registered
2022-10-04
Start date
2022-10-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

community-onset pneumonia

Interventions

None listed

Sponsors

Japan Respiratory Society
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: This systematic review will target participants as follows: Adult patients with community-acquired pneumonia as defined by an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America 2019; Adult patients with nursing and healthcare-associated pneumonia as defined by an official clinical practice guideline of the Japanese Respiratory Society 2017. Study designs for eligible studies will be RCTs and observational studies. Drug-resistant bacteria are defined as "pathogens such as Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus, Acinetobacter baumannii, Stenotrophomonas maltophilia, and ESBL-producing Enterobacteriaceae that are not sensitive to beta-lactam antibiotics, macrolides, or respiratry quinolones. Stenotrophomonas maltophilia ESBL-producing Enterobacteriaceae, and other pathogens".

Exclusion criteria

Exclusion criteria: Pediatric patients under 18 years of age and adult patients with hospital-acquired pneumonia and ventilator-associated pneumonia as defined by an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America 2016

Design outcomes

Primary

MeasureTime frame
risk factors for drug-resistant pathogens in community-onset pneumonia—

Countries

Japan

Contacts

Public ContactYosuke Fukuda

Showa University Koto Toyosu Hospital Department of medicine, Division of Respiratory medicine and Allergology

y.f.0423@med.showa-u.ac.jp03-6204-6000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026